Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection (original) (raw)

• Earl, P.L. et al. T–lymphocyte priming and protection against Friend leukemia by vaccinia–retrovirus env gene recombinant. Science 234, 728–731 (1986).
  Article CAS Google Scholar
• Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K., Desrosiers, R.C. Protective effects of a live attenuated SIV with a deletion in the nef gene. Science 258, 1938–1941 (1992).
  Article CAS Google Scholar
• Almond, N. et al. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus–infected cells. Lancet 345, 1342–1344 (1995).
  Article CAS Google Scholar
• Stahl–Hennig, C. et al. Attenuated SIV imparts immunity to challenge with pathogenic spleen–derived SIV but cannot prevent repair of the nef deletion. Immunol. Lett. 51, 129–135 (1996).
  Article Google Scholar
• Ruprecht, R.M. et al. Vaccination with a live retrovirus: the nature of the protective immune response. Proc. Natl. Acad. Sci. USA 87, 5558–5562 (1990).
  Article CAS Google Scholar
• Desrosiers, R.C. Prospects for live attenuated HIV. Nature Med. 4, 982 (1998).
  Article CAS Google Scholar
• Baba, T.W. et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820– 1825 (1995).
  Article CAS Google Scholar
• Cohen, J. Weakened SIV vaccine still kills. Science 278, 24–25 (1997).
  Article CAS Google Scholar
• Dittmer, U. et al. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212, 392–397 (1995).
  Article CAS Google Scholar
• Dittmer, U. et al. Specificity of helper T cells generated from macaques infected with attenuated Simian Immunodeficiency Virus. J. Gen. Virol. 79, 1801–1807 (1998).
  Article CAS Google Scholar
• Xu, X.N. et al. Evasion of cytotoxic T lymphocyte (CTL) responses by nef–dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus–infected cells. J. Exp. Med. 186, 7– 16 (1997).
  Article CAS Google Scholar
• Johnson, R.P. et al. Induction of vigorous cytotoxic T–lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71, 7711–7718 (1997).
  CAS PubMed PubMed Central Google Scholar
• Norley, S., Beer, B., Binninger–Schinzel, D., Cosma, C. & Kurth, R. Protection from pathogenic SIVmac challenge following short–term infection with a nef–deficient attenuated virus. Virology 219, 195– 205 (1996).
  Article CAS Google Scholar
• Cole, K.S. et al. Evolution of envelope–specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71, 5069–5079 (1997).
  CAS PubMed PubMed Central Google Scholar
• Johnson, R.P. & Desrosiers, R.C. Protective immunity induced by live attenuated simian immunodeficiency virus. Curr. Opin. Immunol. 10, 436–443 (1998).
  Article CAS Google Scholar
• Heilman, C.A. & Baltimore, D. HIV vaccines—where are we going? Nature Med. 4, 532– 534 (1998).
  Article CAS Google Scholar
• Burton, D.R. & Moore, J.P. Why do we not have an HIV vaccine and how can we make one? Nature Med. 4, 495–498 (1998).
  Article CAS Google Scholar
• Morrison, R.P., Nishio, J. & Chesebro, B. Influence of the murine MHC (H–2) on Friend leukemia virus–induced immunosuppression. J. Exp. Med. 163, 301–314 (1986).
  Article CAS Google Scholar
• Ceglowski, W.S. & Friedman, H. Immunosuppression by leukemia viruses. I. Effect of Friend disease virus on cellular and humoral hemolysin responses of mice to a primary immunization with sheep erythrocytes. J. Immunol. 101, 594–604 (1968).
  CAS PubMed Google Scholar
• Jones, S.M., Moors, M.A., Ryan, Q., Klyczek, K.K. & Blank, K.J. Altered Macrophage Antigen–Presenting Cell Function Following Friend Leukemia Virus Infection. Viral Immunol. 5, 201–211 (1992).
  Article CAS Google Scholar
• Kabat, D. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148, 1–42 (1989).
  CAS PubMed Google Scholar
• Hoatlin, M.E. & Kabat, D. Host–range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol. 3, 51–57 (1995).
  Article CAS Google Scholar
• Li, J.–P., D'Andrea, A.D., Lodish, H.F. & Baltimore, D. Activation of cell growth by binding of Friend spleen focus–forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343, 762–764 (1990).
  Article CAS Google Scholar
• Hasenkrug, K.J., Brooks, D. M., Robertson, M. N., Srinivas, R.V. & & Chesebro, B. Immunoprotective determinants in Friend Murine Leukemia Virus envelope protein. Virology 248, 66–73 (1998).
  Article CAS Google Scholar
• Wendling, F. & Tambourin, P.E. Oncogenicity of Friend–virus–infected cells: determination of origin of spleen colonies by the H–2 antigens as genetic markers. Int. J. Cancer 22, 479–86 (1978).
  Article CAS Google Scholar
• Lilly, F. Susceptibility to two strains of Friend leukemia virus in mice. Science 155, 461–462 (1967).
  Article CAS Google Scholar
• Dittmer, U., Brooks, D.M. & Hasenkrug, K.J. Characterization of a live–attenuated retroviral vaccine demonstrates protection via immune mechanisms. J. Virol. 72, 6554–6558 (1998).
  CAS PubMed PubMed Central Google Scholar
• Pincus, T., Rowe, W.P. & Lilly, F. A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to Friend murine leukemia virus. J. Exp. Med. 133, 1234–1241 (1971).
  Article CAS Google Scholar
• Jolicoeur, P. The Fv–1 gene of the mouse and its control of murine leukemia virus replication. Curr. Top. Microbiol. Immunol. 86, 67–122 (1979).
  Article CAS Google Scholar
• Britt, W.J. & Chesebro, B. Use of monoclonal anti–gp70 antibodies to mimic the effects of the Rfv–3 gene in mice with Friend virus–induced leukemia. J. Immunol. 130, 2363–2367 (1983).
  CAS PubMed Google Scholar
• Hasenkrug, K.J., Brooks, D.M. & Chesebro, B. Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T–cell responsiveness. Proc. Natl. Acad. Sci. USA 92, 10492– 10495 (1995).
  Article CAS Google Scholar
• Hasenkrug, K.J., Brooks, D.M. & Dittmer, U. Critical role for CD4+ T cells in controlling retrovirus replication and spread in persistently infected mice. J. Virol. 72, 6559–6564 (1998).
  CAS PubMed PubMed Central Google Scholar
• Perry, L.L. & Lodmell, D.L. Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Virol. 65, 3429–3434 (1991).
  CAS PubMed PubMed Central Google Scholar
• Lodmell, D.L. & Ewalt, L.C. Pathogenesis of street rabies virus infections in resistant and susceptible strains of mice. J. Virol. 55, 788–795 (1985).
  CAS PubMed PubMed Central Google Scholar
• Weidt, G., Deppert, W., Buchhop, S., Dralle, H. & Lehmann–Grube, F. Antiviral protective immunity induced by major histocompatibility complex class I molecule–restricted viral T–lymphocyte epitopes inserted in various positions in immunologically self and nonself proteins. J. Virol. 69, 2654– 2658 (1995).
  CAS PubMed PubMed Central Google Scholar
• Oldstone, M.B. et al. Vaccination to prevent persistent viral infection. J. Virol. 67, 4372–4378 (1993).
  CAS PubMed PubMed Central Google Scholar
• Hom, R.C., Finberg, R.W., Mullaney, S. & Ruprecht, R.M. Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells. J. Virol. 65, 220– 224 (1991).
  CAS PubMed PubMed Central Google Scholar
• Walker, C.M. & Levy, J.A. A diffusable lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66, 628–630 (1989).
  CAS PubMed PubMed Central Google Scholar
• Mackewicz, C. & Levy, J.A. CD8+ cell anti–HIV activity: Nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses 8, 1039–1050 (1992).
  Article CAS Google Scholar
• Furci, L. et al. Antigen–driven C–C chemokine–mediated HIV–1 suppression by CD4+ T cells from exposed uninfected individuals expressing the wild–type CCR–5 allele. J. Exp. Med. 186, 455–460 (1997).
  Article CAS Google Scholar
• Salk, J., Bretscher, P.A., Salk, P.L., Clerici, M. & Shearer, G.M. A strategy for prophylactic vaccination against HIV. Science 260, 1270– 1272 (1993).
  Article CAS Google Scholar
• Emini, E.A. et al. Prevention of HIV–1 infection in chimpanzees by gp120 V3 domain–specific monoclonal antibody. Nature 355, 728–730 (1992).
  Article CAS Google Scholar
• Gauduin, M.C. et al. Passive immunization with a human monoclonal antibody protects hu–PBL–SCID mice against challenge by primary isolates of HIV–1. Nature Med. 3, 1389–93 (1997).
  Article CAS Google Scholar
• Letvin, N.L. Progress in the development of an HIV–1 vaccine. Science 280, 1875–80 (1998).
  Article CAS Google Scholar
• Letvin, N.L. et al. Potent, protective anti–HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA 94, 9378–9383 (1997).
  Article CAS Google Scholar
• Heeney, J.L. et al. β–chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV–1 vaccinated macaques. Proc. Natl. Acad. Sci. USA 95, 10803– 10808 (1998).
  Article CAS Google Scholar
• Chesebro, B. et al. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127, 134–148 (1983).
  Article CAS Google Scholar
• Sitbon, M., Nishio, J., Wehrly, K., Lodmell, D. & Chesebro, B. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual–tropic murine leukemia viruses. Virology 141, 110–108 (1985).
  Article CAS Google Scholar
• Morrison, R.P. et al. Different H–2 subregions influence immunization against retrovirus and immunosuppression. Nature 329, 729–732 (1987).
  Article CAS Google Scholar
• Chesebro, B. et al. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus–induced erythroleukemia cells: Friend–specific and FMR–specific antigens. Virology 112, 131–144 (1981).
  Article CAS Google Scholar